Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Bayer
National Institutes of Health Clinical Center (CC)
Centre Oscar Lambret
City of Hope Medical Center
Daiichi Sankyo
Boehringer Ingelheim
Mayo Clinic
Institut Bergonié
Day One Biopharmaceuticals, Inc.
Merck Sharp & Dohme LLC
Telix Pharmaceuticals (Innovations) Pty Limited
Elevation Oncology
Genentech, Inc.
pharmaand GmbH
M.D. Anderson Cancer Center
Endocyte
Jules Bordet Institute
ImmunoVaccine Technologies, Inc. (IMV Inc.)
Seagen Inc.
Hoffmann-La Roche
Wake Forest University Health Sciences
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
GlaxoSmithKline